Monopar Therapeutics Inc. (MNPR) Financials
MNPR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 138.0 billion | 2.6 billion |
| Dec. 31, 2025 | 140.7 billion | 2.9 billion |
| Sept. 30, 2025 | 144.2 million | 2.6 million |
| June 30, 2025 | 53.9 million | 1.7 million |
MNPR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -3.5 million | ? |
| Dec. 31, 2025 | -3.4 million | 1.1 million |
| Sept. 30, 2025 | -2.1 million | 1.1 million |
| June 30, 2025 | -1.1 million | 1.3 million |
MNPR Net Income
No data available :(
MNPR Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 52.5 billion | 131.6 million | - |
| Dec. 31, 2025 | 61.8 billion | 154.9 million | 154920 |
| Sept. 30, 2025 | 143.7 million | - | 102236 |
| June 30, 2025 | 53.3 million | - | 80366 |
MNPR Shares Outstanding
MNPR Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 4 | 3.5 million | 1.7 billion | - |
| Dec. 31, 2025 | - | 3.9 million | 2.2 million | - |
| Sept. 30, 2025 | 2 | 2.6 million | 1.5 million | - |
| June 30, 2025 | 1 | 1.7 million | 1.5 million | - |
MNPR Cost of Revenue
No data available :(
MNPR
Price: $62.35
52 week price:
Earnings Per Share: -1.93 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 123422
Market Capitalization: 398.5 million